Buscar resultados de ensayos clínicos
Carcinoma, Transitional Cell - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: The Expression and Effect of Cyr61 in Urinary Tract Transitional Cell Carcinoma Condición: Carcinoma, Transitional Cell Fecha: 2010-08-25 |
Recruiting |
Nombre del estudio: A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma After Surgical Resection [IMvigor010] Condición: Carcinoma, Transitional Cell Fecha: 2015-05-19 Intervenciones: Drug: Atezolizumab Atezolizumab will be administered at a dose of 1200 milligrams (mg). |
Not yet recruiting |
Nombre del estudio: Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial Tract Condición: Carcinoma, Transitional Cell Fecha: 2017-02-09 Intervenciones:
|
Withdrawn |
Nombre del estudio: Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma Condición: Urothelial Carcinoma Fecha: 2010-02-18 Intervenciones:
|
Withdrawn |
Nombre del estudio: BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma Condición: Urothelial Carcinoma Fecha: 2014-10-28 Intervenciones: Drug: BIBF1120 BIBF1120 200 mg two times per day orally |
Completed |
Nombre del estudio: 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP Regimen Condición:
Fecha: 2005-09-12 Intervenciones: Drug: Gemcitabine |
Withdrawn |
Nombre del estudio: Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma Condición: Urothelial Carcinoma Fecha: 2013-07-16 Intervenciones:
|
Withdrawn |
Nombre del estudio: Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma Condición: Carcinoma, Transitional Cell Fecha: 2005-09-12 Intervenciones: Drug: Lycopene |
Recruiting |
Nombre del estudio: A Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Urothelial Carcinoma Condición: Urothelial Carcinoma Fecha: 2016-08-16 Intervenciones: Drug: INCB054828 INCB054828 once daily on a 2-weeks-on-therapy and 1-week-off-therapy schedule |
Completed |
Nombre del estudio: Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma Condición: Urothelial Carcinoma Fecha: 2012-05-23 Intervenciones: Drug: Valrubicin Eligible patients will receive percutaneous valrubicin beginning no sooner than 10 days |